Vascular BioSciences Competitors and Similar CompaniesClear all

Vascular BioSciences's competitors and similar companies include Evaheart, ImmunoCellular Therapeutics, BioInvent and Medexus Pharma.

	Vascular BioSciences Vascular BioSciences (VBS) is a biopharmaceutical and medical device company focused on cardiovascular and inflammatory diseases.	Evaheart Evaheart (EVI) is a medical device company providing a ventricular assist system.	ImmunoCellular Therapeutics ImmunoCellular Therapeutics is a clinical-stage biotechnology company developing immune-based therapies for the treatment of various cancers.	BioInvent BioInvent focuses on the discovery and development of antibody-based drugs against cancer.	Medexus Pharma Medexus Pharma is a pharmaceutical company developing therapies for autoimmune diseases and cancer.
Founding Date	Founding Date 1995	Founding Date 2014	Founding Date 2006	Founding Date 1997	Founding Date 2012
Type	Type Private	Type Private	Type Public	Type Public	Type Subsidiary
Tags	Tags Healthcare biotech drug development medical devices medical diagnostics medtech oncology pharma	Tags Healthcare medical devices medtech	Tags Healthcare biotech clinical research drug development healthtech medical devices medical diagnostics oncology pharma therapy	Tags Healthcare biotech drug development medical diagnostics oncology pharma	Tags Healthcare drug development medical devices medtech oncology pharma
Locations	Locations Goleta, US HQ Durham, US	Locations Houston, US HQ	Locations Calabasas, US HQ	Locations Lund, SE HQ	Locations Chicago, US HQ
Employees	Employees 267% decrease	Employees 16	Employees 357% decrease	Employees 118	Employees 106
Valuation ($)	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 15.9 m	Valuation ($) 285.9 m	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) kr226.5m (FY, 2025)	Revenue (est.) N/A
Net income	Net income N/A	Net income N/A	Net income ($14.3m) (FY, 2017)	Net income (kr332.9m) (FY, 2025)	Net income N/A